Clinical Trial

Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder

Name: Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder — clinical trial record (NCT07420816)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TINA

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy of APSTZD compared to one active drug and placebo in insomnia treatment.

Trial Details

NCT Number	NCT07420816
Lead Sponsor	Apsen Farmaceutica S.A.
Conditions	Insomnia, Insomnia Chronic
Enrollment	222 participants
Start Date	2026-03-26
Primary Completion	2027-09-23 (estimated)
Study Completion	2027-09-23 (estimated)
Updated on ClinicalTrials.gov	2026-02-19